908 Devices Förvaltning
Förvaltning kriterier kontrolleras 4/4
908 Devices VD är Kevin Knopp, utsedd i Feb 2012, har en mandatperiod på 14.33 år. totala årliga ersättningen är $ 1.55M, bestående av 32.2% lön 67.8% bonusar, inklusive företagsaktier och optioner. äger direkt 3.54% av företagets aktier, värda $ 11.83M. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 3.4 år respektive 5.3 år.
Viktig information
Kevin Knopp
Verkställande direktör
US$1.6m
Total ersättning
| VD-lön i procent | 32.19% |
| Anställning som VD | 14.3yrs |
| Ägande av VD | 3.5% |
| Ledningens genomsnittliga anställningstid | 3.4yrs |
| Styrelsens genomsnittliga mandatperiod | 5.3yrs |
Senaste uppdateringar av ledningen
Recent updates
MASS: Raised 2026 Revenue Outlook Will Support A Higher Stock Price
Analysts have lifted their price target on 908 Devices stock from $10.00 to $11.00, citing updated assumptions around fair value, revenue growth, discount rate and future P/E that they consider better aligned with the company's current outlook. What’s in the News for 908 Devices 908 Devices raised its full year 2026 revenue guidance, according to a key developments summary.
MASS: Raised 2026 Revenue Outlook Will Support Higher Future P/E Multiple
Analysts have modestly adjusted their price targets on 908 Devices, reflecting updated assumptions for a fair value of $10.00, a slightly higher discount rate, marginally stronger projected revenue growth, a softer profit margin outlook, and a higher future P/E of about 70x. What's in the News 908 Devices raised its full year 2026 revenue guidance to a range of $67.0 million to $70.0 million.908 Devices Looking Better Now (Rating Upgrade)
Summary 908 Devices delivered strong Q1 results, raising full-year revenue guidance after a strategic acquisition in narcotics detection. Adjusted gross margins improved nearly three percentage points to 57%, and operating cash flow turned positive. MASS has a solid balance sheet with nearly $100 million in cash post-acquisition and is debt free, while trading at a reasonable valuation. Read the full article on Seeking AlphaMASS: Raised 2026 Revenue Guidance Will Support Higher Earnings Multiple
Analysts have reset their price target on 908 Devices to $10.00 from $8.00, citing updated assumptions around revenue growth, profitability, and future P/E that feed into a higher fair value estimate and a modestly higher discount rate. What's in the News 908 Devices raised full year 2026 revenue guidance to a range of $67.0 million to $70.0 million, compared with 2025 revenue, with the range described as representing 19% to 25% growth (Corporate Guidance: Raised).908 Devices Inc.'s (NASDAQ:MASS) 29% Price Boost Is Out Of Tune With Revenues
Those holding 908 Devices Inc. ( NASDAQ:MASS ) shares would be relieved that the share price has rebounded 29% in the...Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding
908 Devices Inc. ( NASDAQ:MASS ) shareholders won't be pleased to see that the share price has had a very rough month...908 Devices Inc.'s (NASDAQ:MASS) Share Price Not Quite Adding Up
When close to half the companies in the Electronic industry in the United States have price-to-sales ratios (or "P/S...908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results
NasdaqGM:MASS 1 Year Share Price vs Fair Value Explore 908 Devices's Fair Values from the Community and select yours...US Federal And International Funding Will Expand Global Analysis Markets
The notable increase in 908 Devices’ price target reflects improved outlook due to higher expected revenue growth and an expanded forward P/E, raising the consensus fair value from $6.50 to $9.00. What's in the News 908 Devices raised its 2025 revenue guidance to $54–56 million (13–17% growth), up from prior guidance of $53–55 million.908 Devices Inc.'s (NASDAQ:MASS) Shares Climb 26% But Its Business Is Yet to Catch Up
Despite an already strong run, 908 Devices Inc. ( NASDAQ:MASS ) shares have been powering on, with a gain of 26% in the...
The New Handheld Mass Spectrometer Launch Will Expand Market Reach
Divesting the desktop bioprocessing portfolio boosts cash reserves, streamlines operations, and is expected to enhance margins and cash flow in future years.908 Devices Makes Key Divestiture (Rating Upgrade)
Summary 908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device business, expecting 11% to 15% revenue growth in 2025 with acceleration in 2026. MASS management believes losses will be significantly reduced with the new structure, with positive cash flow next year. Read the full article on Seeking Alpha908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors
The 908 Devices Inc. ( NASDAQ:MASS ) share price has done very well over the last month, posting an excellent gain of...Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
The analysts might have been a bit too bullish on 908 Devices Inc. ( NASDAQ:MASS ), given that the company fell short...908 Devices: Key Investor Now Selling
Summary ARK Invest's recent sales of 908 Devices shares have helped to send the stock to multi-year lows. 908 Devices is seeing decent revenue growth, but large losses and limited financial flexibility raise concerns about future capital needs. The stock's low valuation compared to peers is a positive, but ongoing sales by ARK Invest could exert further downward pressure. Read the full article on Seeking AlphaWhy We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
To the annoyance of some shareholders, 908 Devices Inc. ( NASDAQ:MASS ) shares are down a considerable 29% in the last...We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
When you see that almost half of the companies in the Electronic industry in the United States have price-to-sales...908 Devices Q2 2022 Earnings Preview
908 Devices (NASDAQ:MASS) is scheduled to announce Q2 earnings results on Tuesday, August 9th, before market open. The consensus EPS Estimate is -$0.26 (+3.7% Y/Y) and the consensus Revenue Estimate is $10.79M (+30.5% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 2 downward. Revenue estimates have seen 0 upward revisions and 2 downward.Analys av ersättningar till VD
| Datum | Total ersättning | Lön | Företagets resultat |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$35m |
| Dec 31 2025 | US$2m | US$500k | -US$33m |
| Sep 30 2025 | n/a | n/a | -US$73m |
| Jun 30 2025 | n/a | n/a | -US$81m |
| Mar 31 2025 | n/a | n/a | -US$57m |
| Dec 31 2024 | US$2m | US$498k | -US$53m |
| Sep 30 2024 | n/a | n/a | -US$45m |
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$30m |
| Dec 31 2023 | US$1m | US$475k | -US$36m |
| Sep 30 2023 | n/a | n/a | -US$39m |
| Jun 30 2023 | n/a | n/a | -US$38m |
| Mar 31 2023 | n/a | n/a | -US$37m |
| Dec 31 2022 | US$2m | US$477k | -US$34m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$26m |
| Mar 31 2022 | n/a | n/a | -US$25m |
| Dec 31 2021 | US$760k | US$400k | -US$22m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | n/a | n/a | -US$18m |
| Dec 31 2020 | US$591k | US$284k | -US$13m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$11m |
| Dec 31 2019 | US$445k | US$287k | -US$13m |
Ersättning vs marknad: Kevin s total kompensation ($USD 1.55M ) är under genomsnittet för företag av liknande storlek på US marknaden ($USD 2.45M ).
Ersättning vs inkomst: Ersättningen från Kevin har varit i linje med företagets resultat under det senaste året.
VD OCH KONCERNCHEF
Kevin Knopp (53 yo)
Dr. Kevin J. Knopp, Ph D., Co-Founded 908 Devices Inc. in 2012 and serves as its Chief Executive Officer, President and Director since February 2012. Dr. Knopp Co-Founded Ahura Scientific, Inc. in 2002 and...
Ledningsgrupp
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| Co-Founder | 14.3yrs | US$1.55m | 3.54% $ 11.8m | |
| Co-Founder | 14.4yrs | inga uppgifter | 2.32% $ 7.7m | |
| CFO & Treasurer | 12.3yrs | US$1.14m | 0.35% $ 1.2m | |
| Chief Legal | less than a year | US$1.33m | inga uppgifter | |
| Vice President of Corporate Marketing and Communications | 2.3yrs | inga uppgifter | inga uppgifter | |
| Senior Vice President of Sales and Product Marketing | no data | US$1.03m | 0.15% $ 511.4k | |
| Vice President of Human Resources | 4.4yrs | inga uppgifter | inga uppgifter | |
| Senior Vice President of Products and Production | less than a year | inga uppgifter | 0.12% $ 397.6k | |
| Chief Business & Strategy Officer | less than a year | inga uppgifter | inga uppgifter |
Erfaren ledning: MASS s ledningsgrupp anses vara erfaren ( 3.4 års genomsnittlig anställningstid).
Styrelseledamöter
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| Co-Founder | 14.3yrs | US$1.55m | 3.54% $ 11.8m | |
| Co-Founder | 1.3yrs | inga uppgifter | 2.32% $ 7.7m | |
| Independent Director | 14yrs | US$202.51k | 0.067% $ 223.8k | |
| Independent Director | 5.3yrs | US$200.43k | 0.11% $ 361.9k | |
| Independent Chairman of the Board | 12.8yrs | US$222.51k | 1.31% $ 4.4m | |
| Independent Director | 14yrs | US$200.01k | 0.20% $ 666.1k | |
| Independent Director | 4.3yrs | US$183.34k | 0.12% $ 390.9k | |
| Independent Director | 2yrs | US$175.01k | 0.054% $ 182.0k | |
| Independent Director | less than a year | US$216.63k | 0% $ 0 |
Erfaren styrelse: MASS s styrelse anses vara erfaren ( 5.3 års genomsnittlig mandatperiod).
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/21 21:16 |
| Aktiekurs vid dagens slut | 2026/06/18 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
908 Devices Inc. bevakas av 4 analytiker. 4 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Puneet Souda | Leerink Partners LLC |
| Daniel Arias | Stifel, Equities Research |
| Brendan Smith | TD Cowen |